SCM
AVNS

SG Capital Management’s Avanos Medical AVNS Stock Holding History

SG Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-146,623
Closed -$3.97M – 56
2022
Q4 		$3.97M Buy
+146,623
New +$3.59M 2.22% 19

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Capital Management's AVNS Position: Q1 2023 in Review

SG Capital Management sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 146,623 shares — an estimated $3.97M sold.

SG Capital Management first reported a position in AVNS in Q4 2022 and held it in 1 quarter. The position peaked at $3.97M in Q4 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

  • SG Capital Management reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
  • SG Capital Management sold 146,623 Avanos Medical shares in Q1 2023, an estimated $3.97M.
  • SG Capital Management first reported a position in Avanos Medical in Q4 2022 and held it in 1 quarter.
  • SG Capital Management's Avanos Medical position peaked at $3.97M in Q4 2022.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on SG Capital Management's 13F filing for Q1 2023, filed 12 May 2023.